EBV-Related PTLD

3 registered clinical trials studyying EBV-Related PTLD.

Status	Trial	Sponsor	Phase
Terminated	An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymp NCT05011058	Viracta Therapeutics, Inc.	Phase 2
Completed	Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVAL NCT02973113	Baylor College of Medicine	Phase 1
Completed	Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children NCT02182986	National Institute of Allergy and Infectious Diseases (NIAID)	—